Advanced search

Hypertension in soluble guanylate cyclase alpha(1)-deficient mice is associated with hyperaldosteronism

(2009) In CIRCULATION 120(18, suppl. 2). p.S1045-S1045
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Buys, Emmanuel S, Michael J Raher, Kristen M Rauwerdink, Patrick Sips, Peter Brouckaert, and Kenneth D Bloch. 2009. “Hypertension in Soluble Guanylate Cyclase Alpha(1)-deficient Mice Is Associated with Hyperaldosteronism.” In , 120:S1045–S1045.
APA
Buys, E. S., Raher, M. J., Rauwerdink, K. M., Sips, P., Brouckaert, P., & Bloch, K. D. (2009). Hypertension in soluble guanylate cyclase alpha(1)-deficient mice is associated with hyperaldosteronism (Vol. 120, pp. S1045–S1045). Presented at the 82nd Scientific session of the American Heart Association.
Vancouver
1.
Buys ES, Raher MJ, Rauwerdink KM, Sips P, Brouckaert P, Bloch KD. Hypertension in soluble guanylate cyclase alpha(1)-deficient mice is associated with hyperaldosteronism. 2009. p. S1045–S1045.
MLA
Buys, Emmanuel S, Michael J Raher, Kristen M Rauwerdink, et al. “Hypertension in Soluble Guanylate Cyclase Alpha(1)-deficient Mice Is Associated with Hyperaldosteronism.” Vol. 120. 2009. S1045–S1045. Print.
@inproceedings{8507209,
  author       = {Buys, Emmanuel S and Raher, Michael J and Rauwerdink, Kristen M and Sips, Patrick and Brouckaert, Peter and Bloch, Kenneth D},
  issn         = {0009-7322},
  language     = {eng},
  location     = {Orlando, FL, USA},
  number       = {18, suppl. 2},
  pages        = {S1045--S1045},
  title        = {Hypertension in soluble guanylate cyclase alpha(1)-deficient mice is associated with hyperaldosteronism},
  volume       = {120},
  year         = {2009},
}

Web of Science
Times cited: